Semble has secured fresh funding to expand its healthcare management platform across Europe, supporting growth among outpatient providers and further development of its AI-powered care coordination and workflow management capabilities.
Semble has raised £30 million in a Series C funding round
led by Revaia, with participation from Partech and existing investors Mercia Ventures and Octopus Ventures.
Semble is a UK-based healthcare technology company that
provides a practice management and care coordination platform for outpatient
healthcare providers. Its software helps clinicians, medical practices, and
London-based Semble has secured a £30 million Series C led by Paris-headquartered European growth investor Revaia.
Commure, a healthcare AI platform, has achieved a significant milestone. The company announced a $7 billion valuation after…
Delve gets $32 million from Insight Partners to scale its platform that automates regulatory compliance with AI agents.
Certo raises seed funding to expand its AI-powered compliance platform, helping beauty and consumer goods companies manage…
The startup combines biomarker testing, longitudinal health data and physician-reviewed AI insights to help users detect risks…
The Series D round, led by Leeds Illuminate and Kingfisher Investment, will support Centrical’s global growth and AI tools for…
